Clin2
NCT07374198Possibly a fitNot yet recruiting

Esketamine during breast cancer surgery to reduce depression

DepressionAnxietyS-ketamineBreast Cancer

Treatments studied

Part of Cancer, Mental health, Skin clinical trials.

This study tests whether giving a medication called esketamine during breast cancer surgery can help reduce feelings of depression and anxiety after the operation. If you are having breast cancer surgery and have been feeling down, this treatment might support your emotional well-being during recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
142 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are scheduled for breast cancer surgery.
  • You have symptoms of depression (feeling down, loss of interest, etc.).
  • Your surgery is expected to last at least 90 minutes under anesthesia.
  • You are not taking antidepressants, antipsychotics, or steroid medications.
  • You do not have serious heart, lung, liver, or kidney problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07374211Not yet recruiting
Esketamine for breast cancer surgery patients with severe depression

This trial tests whether a medication called esketamine, given during breast cancer surgery, can help reduce feelings of depression and anxiety after the operation. It is for women who are already experiencing severe depressive symptoms before surgery.

NCT07367542Not yet recruiting
Esketamine for emotional distress during breast cancer surgery

This trial tests whether a medicine called esketamine, given during breast cancer surgery, can help reduce negative emotions like anxiety or depression before and after the operation. It may help you feel more emotionally stable during your treatment.

Beijing
NCT06665568Not yet recruiting· Early Phase 1
Ketamine nasal spray for depression and anxiety in advanced cancer

This study tests whether a ketamine nasal spray can help reduce depression and anxiety in people with advanced cancer. It also looks at how caregivers are affected. If you are living with progressive cancer and feeling down or anxious, this treatment might offer some relief.

Zurich, Canton of Zurich
NCT07247968Recruiting· Early Phase 1
Esketamine with ECT for severe depression in teens

This study tests whether adding a low dose of esketamine (a type of anesthesia) to modified electroconvulsive therapy (ECT) helps treat severe depression in teenagers. It aims to see if this combination works better and is safer than ECT alone.

Chongqing
NCT06773143Recruiting
Esketamine for sleep quality during breast cancer chemo

This trial tests whether a low dose of esketamine can improve sleep quality in women with breast cancer who are receiving neoadjuvant chemotherapy. If you have trouble sleeping during treatment, this study may find a new way to help.

Nanjing, Jiangsu
NCT07315074Recruiting
Esketamine for better sleep after surgery in postmenopausal women

This trial tests if a low dose of esketamine, given during anesthesia, can improve sleep quality after lower-limb fracture surgery in postmenopausal women. It aims to find a safe way to help you rest better after your operation.

Jingjiang, Jiangsu

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.